{"id":762,"date":"2026-09-01T16:45:45","date_gmt":"2026-09-01T16:45:45","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/"},"modified":"2026-09-01T16:45:45","modified_gmt":"2026-09-01T16:45:45","slug":"semax-acth-4-7-pgp-sequence-identity-quality-guide","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/","title":{"rendered":"Gu\u00eda de identidad Semax: Secuencia y pruebas de ACTH(4\u20137)-Pro-Gly-Pro"},"content":{"rendered":"

Semax es el heptap\u00e9ptido sint\u00e9tico Met-Glu-His-Phe-Pro-Gly-Pro, tambi\u00e9n escrito ACTH(4\u20137)-Pro-Gly-Pro. No debe confundirse con semaxanib, una peque\u00f1a mol\u00e9cula no relacionada con un nombre similar.<\/p>

Evidencia de un vistazo<\/h2>
  • La literatura primaria indica la secuencia como Met-Glu-His-Phe-Pro-Gly-Pro.<\/li>
  • La descripci\u00f3n ACTH(4\u20137) identifica el fragmento N-terminal de cuatro residuos seguido de Pro-Gly-Pro.<\/li>
  • La identidad, la pureza, el contenido y la evidencia biol\u00f3gica son cuestiones separadas y necesitan registros separados.<\/li><\/ul><\/div><\/div>
    \"Visualizaci\u00f3n
    Ilustraci\u00f3n anal\u00edtica editorial original. No describe un producto suministrado, un lote liberado, una formulaci\u00f3n aprobada, un resultado de ensayo o un uso cl\u00ednico.<\/figcaption><\/figure>

    Registro de identidad<\/h2>

    Debido a que Semax es corto, en algunos m\u00e9todos anal\u00edticos pueden aparecer fragmentos estrechamente relacionados y productos de eliminaci\u00f3n cerca del objetivo. La masa intacta y un m\u00e9todo cromatogr\u00e1fico adecuado proporcionan pruebas complementarias.<\/p>

    nombre com\u00fan<\/strong>Semax<\/span><\/div>
    Secuencia<\/strong>Met-Glu-Su-Phe-Pro-Gly-Pro<\/span><\/div>
    Notaci\u00f3n de investigaci\u00f3n<\/strong>ACTH(4\u20137)-PGP<\/span><\/div>
    No es sin\u00f3nimo<\/strong>Semaxanib\/SU5416<\/span><\/div>
    Registro de lote principal<\/strong>Secuencia completa, forma terminal, masa intacta, cromatograf\u00eda, contenido y enlace por lotes.<\/span><\/div><\/div><\/div>

    L\u00edmite anal\u00edtico y de evidencia<\/h2>

    El certificado debe indicar la qu\u00edmica terminal y la base utilizada para los c\u00e1lculos de contenido y peso molecular. El agua, los contraiones y los disolventes residuales pueden afectar una masa tal cual sin cambiar la secuencia pept\u00eddica.<\/p>

    La copia editorial debe etiquetar la evidencia actual como trabajo con ratas, ratones o modelos celulares. Evite palabras como \u201cneurorreparaci\u00f3n comprobada\u201d a menos que un estudio comparativo en humanos citado directamente respalde el criterio de valoraci\u00f3n exacto.<\/p>

    Regla editorial<\/h2>

    Indique el material, forma, modelo o poblaci\u00f3n exactos y punto final respaldados por el registro citado. No convierta la verosimilitud mecanicista, un resultado en animales, la etiqueta de un medicamento terminado o una prueba anal\u00edtica en una afirmaci\u00f3n sobre un lote de cat\u00e1logo no relacionado.<\/p>","protected":false},"excerpt":{"rendered":"

    Semax es el heptap\u00e9ptido sint\u00e9tico Met-Glu-His-Phe-Pro-Gly-Pro, tambi\u00e9n escrito ACTH(4\u20137)-Pro-Gly-Pro. No debe confundirse con semaxanib, una peque\u00f1a mol\u00e9cula no relacionada con un nombre similar.<\/p>","protected":false},"author":1,"featured_media":746,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"361","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Sequence identity anchored to primary preclinical literature","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, study size, model\/population limits and relevant conflicts are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary\/regulatory sources, factual claims, numerical results, limitations and product-evidence boundary checked for batch 3.","pim_creation_method":"The editorial workflow began with linked PubMed primary papers, systematic reviews, PubChem identity records and FDA\/DailyMed regulatory records. Population or model, denominators, endpoints, numerical results, null findings, limitations and conflicts were extracted before drafting. AI-assisted drafting and original image generation were used; the final facts and evidence boundaries were checked against the linked records on 2026-09-02. This is not independent peer review.","pim_sources":"[{\"title\":\"Semax and rat brain gene expression after ischemia\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39767736\/\",\"note\":\"Primary 2024 rat RNA-seq study; PMID 39767736.\"},{\"title\":\"Semax in a female-mouse spinal-cord-injury model\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40692165\/\",\"note\":\"Primary 2025 preclinical study; PMID 40692165.\"},{\"title\":\"Semax protein-expression study in rat cerebral ischemia\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34201112\/\",\"note\":\"Sequence and preclinical context; PMID 34201112.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-762","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"\nSemax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing<\/title>\n<meta name=\"description\" content=\"Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, also written ACTH(4\u20137)-Pro-Gly-Pro. It should not be confused with semaxanib, an unrelated\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing\" \/>\n<meta property=\"og:description\" content=\"Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, also written ACTH(4\u20137)-Pro-Gly-Pro. It should not be confused with semaxanib, an unrelated\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T16:45:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/semax-identity-quality.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/\"},\"wordCount\":252,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/semax-identity-quality.webp\",\"articleSection\":[\"Evidence & Quality Guides\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/\",\"name\":\"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/semax-identity-quality.webp\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"description\":\"Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, also written ACTH(4\u20137)-Pro-Gly-Pro. It should not be confused with semaxanib, an unrelated\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/semax-identity-quality.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/semax-identity-quality.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: Peptide laboratory visualization of the seven-residue Semax sequence and LC-MS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semax-acth-4-7-pgp-sequence-identity-quality-guide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gu\u00eda de identidad Semax: Secuencia y pruebas de ACTH(4\u20137)-Pro-Gly-Pro","description":"Semax es el heptap\u00e9ptido sint\u00e9tico Met-Glu-His-Phe-Pro-Gly-Pro, tambi\u00e9n escrito ACTH(4\u20137)-Pro-Gly-Pro. No debe confundirse con semaxanib, un medicamento no relacionado...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/","og_locale":"es_ES","og_type":"article","og_title":"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing","og_description":"Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, also written ACTH(4\u20137)-Pro-Gly-Pro. It should not be confused with semaxanib, an unrelated\u2026","og_url":"https:\/\/nhdbio.com\/es\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/","og_site_name":"NHD","article_published_time":"2026-09-01T16:45:45+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/semax-identity-quality.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing","datePublished":"2026-09-01T16:45:45+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/"},"wordCount":252,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/semax-identity-quality.webp","articleSection":["Evidence & Quality Guides"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/","url":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/","name":"Gu\u00eda de identidad Semax: Secuencia y pruebas de ACTH(4\u20137)-Pro-Gly-Pro","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/semax-identity-quality.webp","datePublished":"2026-09-01T16:45:45+00:00","description":"Semax es el heptap\u00e9ptido sint\u00e9tico Met-Glu-His-Phe-Pro-Gly-Pro, tambi\u00e9n escrito ACTH(4\u20137)-Pro-Gly-Pro. No debe confundirse con semaxanib, un medicamento no relacionado...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/semax-identity-quality.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/semax-identity-quality.webp","width":1672,"height":941,"caption":"AI-generated illustration: Peptide laboratory visualization of the seven-residue Semax sequence and LC-MS"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/semax-acth-4-7-pgp-sequence-identity-quality-guide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Semax Identity Guide: ACTH(4\u20137)-Pro-Gly-Pro Sequence and Testing"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=762"}],"version-history":[{"count":0,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/762\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/746"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}